Importantly, pharmacological blockade of Nlrp3 reduced inflammation caused by cytotoxic CD8+ T cells in this mouse model of MCL, thus identifying this inflammasome, as well as CD8+ T cell-mediated cytotoxicity, as potential targets for immunotherapy. Here, CD8A is linked to mantle cell lymphoma.